Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Trauma-Focused Managing Cancer And Living Meaningfully (CALM-TF): A Phase III Randomized Controlled Trial of an Intervention Targeting Traumatic Stress in Patients With Advanced Ovarian Cancer

NCT07286162 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT07286162
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07286162 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Trauma-Focused Managing Cancer And Living Meaningfully (CALM-TF): A Phase III Randomized Controlled Trial of an Intervention Targeting Traumatic Stress in Patients With Advanced Ovarian Cancer
Lead sponsor
University Health Network, Toronto
Phase
Phase 3
Overall status
Not yet recruiting
Start date
March 1, 2026
Completion date
December 31, 2031
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer (ovca), recurrent ovarian cancer